Hite Hedge Asset Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Hite Hedge Asset Management LLC

  • $971 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$9.03 - $21.55 $115,295 - $275,150
-12,768 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$15.0 - $22.83 $54,435 - $82,850
-3,629 Reduced 22.13%
12,768 $267,000
Q2 2021

Aug 13, 2021
BUY
$29.06 - $38.83 $476,496 - $636,695
16,397 New
16,397 $476,000

Others Institutions Holding BTAI

# of Institutions
77
Shares Held
6.6M
Call Options Held
85K
Put Options Held
221K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $35.9M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Hite Hedge Asset Management LLC Portfolio

Follow Hite Hedge Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hite Hedge Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hite Hedge Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email